Colinz Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE923C01011
  • NSEID:
  • BSEID: 531210
INR
46.00
0.15 (0.33%)
BSENSE

Dec 12

BSE+NSE Vol: 4.14 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Desh Rakshak
Ishita Drugs
Colinz Labs
Zenith Health
Shree Ganesh Bio
Chandra Bhagat
Starsource Multi
Cian Healthcare
Vilin Bio Med
Saroja Pharma In
Medicamen Organ.
Why is Colinz Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a -2.31% CAGR growth in Net Sales over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.37
  • The company has been able to generate a Return on Equity (avg) of 4.90% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 25
  • OPERATING CF(Y) Lowest at Rs -1.45 Cr
  • DEBTORS TURNOVER RATIO(HY) Lowest at 0.76 times
3
With ROE of 4.7, it has a Very Expensive valuation with a 2.1 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -33.20%, its profits have fallen by -9%
4
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 1.78% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -33.20% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Colinz Labs for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Colinz Labs
-33.2%
-0.57
58.05%
Sensex
4.89%
0.41
11.85%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.31%
EBIT Growth (5y)
2.47%
EBIT to Interest (avg)
0.37
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.75
Tax Ratio
19.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.95%
ROE (avg)
4.90%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
46
Industry P/E
34
Price to Book Value
2.13
EV to EBIT
14.27
EV to EBITDA
14.27
EV to Capital Employed
4.57
EV to Sales
2.43
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.37%
ROE (Latest)
4.66%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 74.20 cr

-4What is not working for the Company
OPERATING CF(Y)

Lowest at Rs -1.45 Cr

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.76 times

Loading Valuation Snapshot...
Here's what is working for Colinz Labs
Cash and Cash Equivalents - Half Yearly
Highest at Rs 74.20 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Colinz Labs
Operating Cash Flow - Annually
Lowest at Rs -1.45 Cr
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 0.76 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio